Shanghai Xinzhi Medical Technology Co., Ltd. announced a private placement of common shares for the gross proceeds of CNY 15 million on April 14, 2023. The transaction will include participation from new investor Shanghai Bio-heart Biological Technology Co., Ltd. Post completion, Shanghai Bio-heart Biological Technology Co., Ltd. will hold 14.79% stake in exchange for CNY 361,144 of registered capital of the company.
Shanghai Bio-heart Biological Technology Co., Ltd.
Equities
2185
CNE100004JH3
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 HKD | -6.10% | -8.26% | -41.52% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.52% | 66.37M | |
+8.38% | 124B | |
-6.35% | 11.02B | |
+1.56% | 8.88B | |
+36.32% | 5.45B | |
-21.55% | 4.74B | |
+8.20% | 3.44B | |
-7.69% | 2.84B | |
-8.42% | 2.15B | |
-5.20% | 2.11B |
- Stock Market
- Equities
- 2185 Stock
- News Shanghai Bio-heart Biological Technology Co., Ltd.
- Shanghai Xinzhi Medical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Shanghai Bio-heart Biological Technology Co., Ltd.